Real-world evidence (RWE) studies are becoming increasingly important in healthcare decision-making. There are various study designs used to generate RWE, each with their unique benefits:
[1] Cohort Studies: Cohort studies are observational in nature, where two or more groups (cohorts) distinguished by their exposure to a certain factor (like a medical treatment or lifestyle choice) are followed and assessed to determine the effect of that exposure. These studies are advantageous in studying rare outcomes, multiple outcomes, or outcomes that take a long time to develop.
[2] Case-Control Studies: These studies start with the outcome and then look backward to find the exposure. They’re efficient for studying rare diseases or diseases with a long latency period, as well as multiple exposures. However, they may not be as reliable as cohort studies due to potential recall bias.
[3] Cross-Sectional Studies (Prevalence Studies): These studies observe a defined population at a single point in time or time interval. They’re useful in understanding the burden of a disease in a population, assessing public health needs, and planning healthcare services.
[4] Registry-Based Studies: These are observational studies where data are collected prospectively or retrospectively for patients with a particular condition or who are undergoing a specific procedure. Registry-based studies provide long-term, real-life data about prognosis, adverse events, quality of life, and cost-effectiveness.
[5] Pragmatic Clinical Trials (PCTs): Unlike traditional randomized clinical trials, PCTs are designed to determine the effectiveness of interventions in real-world routine practice conditions. They often include a more diverse patient population, multiple care settings, and less rigid protocols.
[6] Retrospective Studies: This involves analyzing existing datasets (like EHRs or insurance claims databases) to find associations or trends. This is also known as secondary use of existing data. While these are generally quicker and less expensive, they are subject to the limitations of the existing data, which may not have been collected for research purposes.
[7] Prospective Observational Studies: In these studies, subjects are followed over time with data collected about various factors that might influence the outcome of interest. These studies are useful in understanding the natural history of disease and the effectiveness of different treatments in the real world. These studies usually include both secondary data (data collected for a different purpose) and primary data (data collected specifically for the purposes of the study).
Share this story...
Real World Evidence (RWE) 101 – HIPAA
RWE 101 - HIPAA HIPAA (Health Insurance Portability and Accountability Act), enacted in 1996, is a federal law in the United States that establishes regulations for the protection of [...]
Real World Evidence (RWE) 101 – The Common Rule
RWE 101 - The Common Rule The Common Rule plays a significant role in the governance of observational studies. The Common Rule refers to a set of regulations and [...]
Real World Evidence (RWE) 101 – The Tuskegee Syphilis Study (the reason we have the Belmont Report and the Common Rule)
RWE 101 - The Tuskegee Syphilis Study (the reason we have the Belmont Report and the Common Rule) The Tuskegee Syphilis Study, conducted from 1932 to 1972, stands as [...]
Real World Evidence (RWE) 101 – Observational Study vs Non-Interventional Study
RWE 101 - Observational Study vs Non-Interventional Study In the context of real-world evidence (RWE), the terms "observational study" and "non-interventional study" are often used interchangeably to refer to [...]
Real World Evidence (RWE) 101 – Are Non-Interventional Studies Regulated?
RWE 101 - Are Non-Interventional Studies Regulated? Yes, non-interventional studies (NIS) are regulated. While the specific regulations and requirements may vary by country, there are generally guidelines and provisions [...]
Real World Evidence (RWE) 101 – Postmarket Requirements (PMR) vs Post-Authorisation Safety Studies (PASS)
RWE 101 - Postmarket Requirements (PMR) vs Post-Authorisation Safety Studies (PASS) In the context of real-world evidence (RWE) and regulatory frameworks, postmarket requirements (PMRs) and post-authorization safety studies (PASS) [...]







